Immunocompromised children and young people are at no increased risk of severe COVID-19
- PMID: 34785268
- PMCID: PMC8590622
- DOI: 10.1016/j.jinf.2021.11.005
Immunocompromised children and young people are at no increased risk of severe COVID-19
Abstract
Objectives: We aimed to prospectively describe the incidence and clinical spectrum of SARS-CoV-2 infection in immunocompromised paediatric patients in the UK.
Methods: From March 2020 to 2021 weekly questionnaires were sent to immunocompromised paediatric patients or their parents. Information, including symptom presentation and SARS-CoV-2 PCR test results, was collected from 1527 participants from 46 hospitals. Cross-sectional serology was investigated in February and March 2021.
Results: Until the end of September 2020, no cases were reported. From September 28th 2020 to March 2021 a total of 38 PCR-detected SARS-CoV-2 infections were reported. Of these, four children were admitted to hospital but none had acute severe COVID-19. Increasing age in association with immunodeficiency increased reporting of SARS-CoV-2 infection. Worsening of fever, cough, and sore throat were associated with participants reporting SARS-CoV-2 infection. Serology data included 452 unvaccinated participants. In those reporting prior positive SARS-CoV-2 PCR, there were detectable antibodies in 9 of 18 (50%). In those with no prior report of infection, antibodies were detected in 32 of 434 (7•4%).
Conclusions: This study shows SARS-CoV-2 infections have occurred in immunocompromised children and young people with no increased risk of severe disease. No children died.
Keywords: COVID-19; Children; Immunocompromised; SARS-CoV-2.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest All authors have completed ICMJE disclosure forms. HdG received grant funding from the BPAIIG for the submitted work; there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Comment in
-
Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".J Infect. 2022 Jul;85(1):90-122. doi: 10.1016/j.jinf.2022.04.020. Epub 2022 Apr 10. J Infect. 2022. PMID: 35417737 Free PMC article.
-
Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.J Infect. 2022 Sep;85(3):e56-e58. doi: 10.1016/j.jinf.2022.05.043. Epub 2022 Jun 18. J Infect. 2022. PMID: 35724755 Free PMC article. No abstract available.
References
-
- Livingston E., Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323:1335. - PubMed
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239–1242. - PubMed
-
- de Lusignan S., Dorward J., Correa A., Jones N., Akinyemi O., Amirthalingam G., et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20:1034–1042. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous